Primum non nocere – “First do no harm” is a key principle in healthcare. In times of Covid-19, however, this is easier said than done: The benefits of diagnostic procedures and therapies must be weighed against the potential infection risk imposed upon the patient. Keep reading to find out more. Enjoy!
 |
Sponsored • AI assistance for colonoscopyEnsuring Patient Safety in EndoscopyPatient safety in endoscopy must be approached from a holistic perspective, through solutions which increase detection rates of abnormalities, increase confidence in the safety of the reprocessing outcome, and control the risk of infection and ... |
 |
Article • Workplace inclusionSurgery in a wheelchair: breaking barriers in the OR and beyondYou don’t need to stand up to stand out. A few decades ago, a little boy believed he could tend to patients in spite of being in a wheelchair – and he did. During the EANS 2020 virtual meeting, Prof. Dr. Thomas Kapapa explained how he breaks ... |
 |
Article • Study delivers screening adviceBreast cancer: Detection during, not between screenings is bestTumours with the same biology have different prognoses based on their method of detection, and this information should be taken into account when deciding which treatments might be needed, a Dutch researcher explained at the 12th European Breast ... |
 |
Video • X-ray imagingAgfa: Digital Tomosynthesis (DTS) for direct radiographyIn clinical practice, planar X-ray images are usually the first imaging technique used. In musculoskeletal imaging, this can be a shoulder in AP and lateral projection. In many of these cases, the 2D technique is not sufficiently informative and ... |
 |
Article • Immunotherapy, iRecist and complicationsLung cancer imaging (in a post-Covid world)The evolving area of immunotherapies in lung cancer and the role of iRecist treatment assessment protocols were investigated during a virtual session organised by the British Institute of Radiology (BIR). Consultant radiologist Dr Charlie Sayer, ... |
 |
Article • Finding therapeutic targetsPancreatic cancer: Seeking viable treatment strategiesPancreatic cancer has the worst survival rate of any cancers, with immunotherapies currently offering negligible treatment benefits for patients. To help identify new therapeutic approaches, researchers from the University of Oxford have been ... |
EUROPEAN HOSPITAL issue 4/2020 is out! Click here to read the ePaper
You are receiving this email because you subscribed to our newsletter on healthcare-in-europe If you don’t want to receive this newsletter anymore, click here to unsubscribe. Keep up-to-date on the latest news from all hospital-related fields! Copyright © 2024 mgo fachverlage GmbH & Co. KG. E.-C.-Baumann-Straße 5, 95326 Kulmbach, Germany |
   |